FR2133979A1 - - Google Patents

Info

Publication number
FR2133979A1
FR2133979A1 FR7214052A FR7214052A FR2133979A1 FR 2133979 A1 FR2133979 A1 FR 2133979A1 FR 7214052 A FR7214052 A FR 7214052A FR 7214052 A FR7214052 A FR 7214052A FR 2133979 A1 FR2133979 A1 FR 2133979A1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7214052A
Other languages
French (fr)
Other versions
FR2133979B1 (cg-RX-API-DMAC7.html
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck & Cie
Merck and Co Inc
Original Assignee
Merck & Cie
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Cie, Merck and Co Inc filed Critical Merck & Cie
Publication of FR2133979A1 publication Critical patent/FR2133979A1/fr
Application granted granted Critical
Publication of FR2133979B1 publication Critical patent/FR2133979B1/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
    • C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
    • C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
    • C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
    • C07D235/16—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62—Benzothiazoles
    • C07D277/64—Benzothiazoles with only hydrocarbon or substituted hydrocarbon radicals attached in position 2

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR7214052A 1971-04-21 1972-04-20 Expired FR2133979B1 (cg-RX-API-DMAC7.html)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13618671A 1971-04-21 1971-04-21
US13818671A 1971-04-21 1971-04-21

Publications (2)

Publication Number Publication Date
FR2133979A1 true FR2133979A1 (cg-RX-API-DMAC7.html) 1972-12-01
FR2133979B1 FR2133979B1 (cg-RX-API-DMAC7.html) 1975-10-31

Family

ID=26834087

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7214052A Expired FR2133979B1 (cg-RX-API-DMAC7.html) 1971-04-21 1972-04-20

Country Status (4)

Country Link
DE (1) DE2219408A1 (cg-RX-API-DMAC7.html)
FR (1) FR2133979B1 (cg-RX-API-DMAC7.html)
GB (1) GB1356763A (cg-RX-API-DMAC7.html)
NL (1) NL7204972A (cg-RX-API-DMAC7.html)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2011258217B2 (en) * 2010-05-26 2016-12-15 Sunovion Pharmaceuticals Inc. Heteroaryl compounds and methods of use thereof
CN111944340A (zh) * 2020-08-21 2020-11-17 何瑞坚 一种耐盐雾防锈涂料

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6667300B2 (en) 2000-04-25 2003-12-23 Icos Corporation Inhibitors of human phosphatidylinositol 3-kinase delta
LT2612862T (lt) 2004-05-13 2017-01-25 Icos Corporation Chinazolinonai kaip žmogaus fosfatidilinozitol-3-kinazės delta inhibitoriai
US9492449B2 (en) 2008-11-13 2016-11-15 Gilead Calistoga Llc Therapies for hematologic malignancies
KR20170060179A (ko) 2008-11-13 2017-05-31 길리아드 칼리스토가 엘엘씨 혈액 종양에 대한 요법
AU2010229968A1 (en) 2009-03-24 2011-10-13 Gilead Calistoga Llc Atropisomers of2-purinyl-3-tolyl-quinazolinone derivatives and methods of use
JP2012524126A (ja) 2009-04-20 2012-10-11 ギリアド カリストガ リミテッド ライアビリティ カンパニー 固形腫瘍の治療方法
CA2768843A1 (en) 2009-07-21 2011-01-27 Gilead Calistoga Llc Treatment of liver disorders with pi3k inhibitors
JP6106603B2 (ja) * 2011-01-11 2017-04-05 スノビオン プハルマセウトイカルス インコーポレイテッド ヘテロアリール化合物及びその使用方法
ES2848273T3 (es) 2012-03-05 2021-08-06 Gilead Calistoga Llc Formas polimórficas de (S)-2-(1-(9H-purin-6-ilamino)propilo)-5-fluoro-3-fenilquinazolina-4(3H)-ona
JP2017500319A (ja) 2013-12-20 2017-01-05 ギリアード カリストガ エルエルシー (s)−2−(1−(9h−プリン−6−イルアミノ)プロピル)−5−フルオロ−3−フェニルキナゾリン−4(3h)−オンの塩酸塩の多形形態
EP3083630B1 (en) 2013-12-20 2019-08-21 Gilead Calistoga LLC Process methods for phosphatidylinositol 3-kinase inhibitors
US11021467B2 (en) 2014-06-13 2021-06-01 Gilead Sciences, Inc. Phosphatidylinositol 3-kinase inhibitors

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
NEANT *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2011258217B2 (en) * 2010-05-26 2016-12-15 Sunovion Pharmaceuticals Inc. Heteroaryl compounds and methods of use thereof
EP2576540B1 (en) * 2010-05-26 2019-09-04 Sunovion Pharmaceuticals Inc. Heteroaryl compounds and methods of use thereof
CN111944340A (zh) * 2020-08-21 2020-11-17 何瑞坚 一种耐盐雾防锈涂料

Also Published As

Publication number Publication date
NL7204972A (cg-RX-API-DMAC7.html) 1972-10-24
GB1356763A (en) 1974-06-12
DE2219408A1 (de) 1972-10-26
FR2133979B1 (cg-RX-API-DMAC7.html) 1975-10-31

Similar Documents

Publication Publication Date Title
FR2148481B1 (cg-RX-API-DMAC7.html)
DK133655C (cg-RX-API-DMAC7.html)
DK139415C (cg-RX-API-DMAC7.html)
FR2133979B1 (cg-RX-API-DMAC7.html)
DK139282C (cg-RX-API-DMAC7.html)
DK136186C (cg-RX-API-DMAC7.html)
DE2135052C3 (cg-RX-API-DMAC7.html)
DK129358C (cg-RX-API-DMAC7.html)
DE7148302U (cg-RX-API-DMAC7.html)
DK139842C (cg-RX-API-DMAC7.html)
FR2088404B1 (cg-RX-API-DMAC7.html)
DK131234C (cg-RX-API-DMAC7.html)
CS152163B1 (cg-RX-API-DMAC7.html)
DE2160648A1 (cg-RX-API-DMAC7.html)
CS149136B1 (cg-RX-API-DMAC7.html)
CS149137B1 (cg-RX-API-DMAC7.html)
CS151766B1 (cg-RX-API-DMAC7.html)
DE2145629A1 (cg-RX-API-DMAC7.html)
CS151374B1 (cg-RX-API-DMAC7.html)
CH560300A5 (cg-RX-API-DMAC7.html)
CH604254B5 (cg-RX-API-DMAC7.html)
DD98333A5 (cg-RX-API-DMAC7.html)
BG18323A1 (cg-RX-API-DMAC7.html)
DD104921A5 (cg-RX-API-DMAC7.html)
DD96156A5 (cg-RX-API-DMAC7.html)

Legal Events

Date Code Title Description
ST Notification of lapse